Presentations

Week 12
All Weeks
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
Week 7
Week 8
Week 9
Week 10
Week 11
Week 12
^
A Primary Role for Insulin Therapy in Type 2 Diabetes- Week 12

Hannele Yki-Järvinen

Discussion

Bihormonal Glucose Management Systems - Week 12

Steven J. Russell, MD, PhD

Discussion

 

Connaught laboratories and the Sanofi Insulin Story - Week 12

Sandra Silvestri, MD

Discussion

The Challenge of Insulin in Primary Care - Week 12

Dr. Stewart Harris

 

Discussion

The Genetics of Insulin – From Cloning to Human Disease - Week 12

Dr. Graeme Bell

 

Discussion

Mechanisms of Glucose Sensing - Week 12

Prof Sabrina Diano

Read the Abstract
 

Discussion

Adjunctive Approaches to Insulin Therapy in Type 1 Diabetes - Week 11

Bruce A. Perkins, MD, MPH

 

Discussion

 

Insulin Action in Blood Vessels - Week 11

George L. King, MD

 

Discussion

How does Insulin Act on the Liver? - Week 11

Allan Cherrington, PhD

 

Discussion

Immune-based Therapies for Type 1 Diabetes - Week 10

Matthias von Herrath

Read the Abstract

Discussion

The Present and Future of Pancreas and Islet Transplantation - Week 10
Therapy of Type 1 Diabetes: The DCCT-EDIC Trials - Week 10

David M. Nathan, MD

 Read the Abstract

Discussion

Therapeutic Approaches to Circumventing Autoimmunity- Week 10

Kevan Herold, MD

 

Discussion

Evolving Technologies for the Management of Diabetes and Pregnancy - Week 9

Denice Feig, MD

 

Discussion

Insights from the T1D Exchange Experience - Week 9

David Maahs, MD, PhD  

Discussion

Novel Strategies for Defeating Islet Autoimmunity - Week 8

Pere Santamaria

 

Discussion

Islet Inflammation and Type 1 Diabetes – New Perspectives - Week 8

Decio L. Eizirik, MD, PhD  

 

Discussion

The Bleeding Edge: Open Source Algorithms, Research & What’s Next in Do-It-Yourself Artificial Pancreas Systems - Week 7

Dana Lewis

 

Discussion

New Closed Loop Insulin Systems - Week 7

Roman Hovorka, PhD

Read the Abstract

 

Discussion

Whither the Future of Insulin Management in Type 2 Diabetes? - Week 7

John Buse, MD, PhD

 

Discussion

Defining the Underlying Defect in Insulin Action in Diabetes - Week 6

C. Ronald Kahn 

Read the Abstract

 

Discussion

Defining the Underlying Defect in Insulin Action in Diabetes - Week 6

C. Ronald Kahn

Read the Abstract

 

Discussion

Insulin Action in the Kidney - Week 6

Richard Coward

 

Discussion

The Future of Smart Insulin Delivery - Week 5

Michael A. Weiss

Read the Abstract

 

Discussion

Realizing the Promise of Stem Cell Therapy - Week 5

Douglas Melton, PhD

 

 

Discussion

Molecular Insights Into Islet Autoimmunity - Week 4

Alice Long, PhD

 

Discussion

Preventing Type 1 Diabetes - Week 4

Carla J. Greenbaum, MD

 

Discussion

Global Challenges in the Insulin Supply Change - Week 3

Jean Claude Mbanya, MD, PhD, FRCP

Read the Abstract

 

Discussion

Barriers to Insulin Use in Adults- Week 3

Irl B. Hirsch, MD, MACP

 

Discussion

Insulin and Beyond in the Hospitalized Patient - Week 3

Guillermo E. Umpierrez, MD, CDE  

 

Discussion

Minimizing Hypoglycemia in the Real World - Week 2

Chantal Mathieu, MD, PhD 

Read the Abstract

Discussion

Cellular Consequences of Hypoglycemia - Week 2

Rory McCrimmon, MBChB, MD

Read the Abstract  
 

Discussion

Clinical Consequences of Hypoglycemia - Week 2

Stephanie Amiel, BSc, MBBS, MD, FRCP

Read the Abstract
 

Discussion

The Eli Lilly Insulin Story - Week 1

Ruth E. Gimeno, PhD 

Discussion

The Novo Nordisk Insulin Story - Week 1

Peter Kurtzhals, PhD

Discussion

Historical context at the University of Toronto - Week 1

Bernard Zinman

Read the Abstract

 

Discussion

CSS is here